Summary

The mice model market is projected to reach USD 2.7 billion by 2028 from USD 1.4 billion in 2023, at a CAGR of 13.9% during the forecast period. The key factors driving the growth of the mice model market are its various advantages in the drug discovery sector, and the high efficiency of the technologies. However, the presence of alternative animal research models is expected to restrain market growth to a certain extent.
The mice model market has been segmented based on model types & services, technology, application, end user, and region.
“By application, the PDx models/ xenografts segment accounted for the largest share of the mice model market”
Based on application, the mice model market is categorized into drug discovery and development, basic research, and PDX models/ xenografts. The PDx models/ xenografts segment dominated the market in 2022, owing to the growing preference for personalized medicine in immunodeficient mice models. Personalized medicines are designed through the use of mice models.
“By end user, the pharmaceutical & biotechnology companies segment accounted for the largest share in the mice model market”
Based on end user, the Mice model market is segmented into academic & research institutions, pharmaceutical & biotechnology companies, contract research organizations (CROs) and contract development & manufacturing organizations. In 2022, the pharmaceutical and biotechnology companies’ segment accounted for a larger share of the mice model market. Growth in this market segment can be attributed to the increasing expenditure on R&D by companies for drug development.
 
“North America: the largest share of the mice model market”
North America accounted for the largest share of the mice model market. The large share of the North America region can be attributed to a rise in the preclinical activities by contract research organizations and the biopharmaceutical companies, and a significant increase in the biomedical research. Moreover, presence of key players in the mice model market in the U.S. are propelling the growth of the market.
“Asia Pacific: The fastest-growing region in the mice model market.”
The Asia Pacific mice model market is projected to grow at the highest CAGR during the forecast period. This is attributed to increasing numbers of both domestic and international market players which are focusing on increasing their prescence in the region. Meanwhile, domestic players are expanding their international reach through partnerships, collaborations, agreements, and expansions. Moreover, increasing demand for personalized medicine and regenerative medicine, international alliances for R&D activities in China, and mandatory animal testing for pharmaceutical drugs & cosmetics.
The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 60% and Demand Side 40%
• By Designation: Executives - 40%, Research Scientists- 30%, and Managers - 30%
• By Country: North America- 22%, Europe- 42%, Asia Pacific- 11%, Latin America- 20%, and MEA- 5%
Prominent Players
• Charles River Laboratories (US)
• The Jackson Laboratory (US)
• Inotiv (US)
• genOway (France)
• Taconic Biosciences, Inc. (US)
• Janvier Labs (France)
• Harbour BioMed (China)
• Trans Genic Inc. (Japan)
• Ingenious Targeting Laboratory (US)
• PolyGene AG (Switzerland)
• Aragen Life Sciences Ltd. (India)
• Cyagen Biosciences (US)
• Crown Biosciences (US)
• TransCure bioServices (France)
• Ozgene Pty. Ltd. (Australia)
• The Andersons, Inc. (US)
• Allentown, LLC (US)
• Innovive (US)
• Lab Products, LLC. (US)
• Crescendo Biologics Limited (UK)
• ImmunoGenes (Hungary)
• Lexicon Pharmaceuticals, Inc. (US)
• Horizon Discovery Ltd (UK)
• Marshall BioResources (US)
• Applied StemCell Inc. (US)
Research Coverage:
This report provides a detailed picture of the mice model market. It aims at estimating the size and future growth potential of the market across different segments, such as the model types and services (model types, services), technology (CRISPR/CAS9, microinjection, embryonic stem cell injection, nuclear transfer, and other technologies), application (drug discovery & development, basic research, and PDx models/xenografts), end user (academic & research institutes, pharma & biotech companies, and CROs & CDMOs), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall mice model market and its segments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, trends, opportunities, and challenges.
The report provide insights on the following pointers”
• Analysis of key drivers (rising investments in mouse-model based research, increasing demand of mouse-based clinical trials (MCTs) for more productive outcomes, and the growing preference for personalized medicine), restraints (introduction of 3D-printed mouse models), opportunities (utilization of CRISPR in biomedical research), and challenges (development of alternative animal testing methods) . influencing the growth of the mice model market.
• Product Development/ Innovation: Detailed insights on upcoming technologies, research and development activities, and new models & services launches in the mice model market.
• Market Development: Comprehensive information about lucrative markets- the report analyses the mice model market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the mice model market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Charles River Laboratories (US) (US), The Jackson Laboratory (US), Inotiv (US), genOway (France), and Taconic Biosciences, Inc. (US) among others in the mice model market strategies. The report also helps stakeholders understand the pulse of the animal research model market and provides them information on key market drivers, restraints, challenges and opportunities.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 37
1.1 STUDY OBJECTIVES 37
1.2 MARKET DEFINITION 37
1.2.1 INCLUSIONS AND EXCLUSIONS 37
1.3 STUDY SCOPE 38
1.4 YEARS CONSIDERED 38
1.5 CURRENCY CONSIDERED 39
1.6 RESEARCH LIMITATIONS 39
1.7 STAKEHOLDERS 39
1.7.1 RECESSION IMPACT 39
2 RESEARCH METHODOLOGY 40
2.1 RESEARCH DATA 40
FIGURE 1 RESEARCH DESIGN 40
2.1.1 SECONDARY DATA 40
2.1.2 PRIMARY DATA 41
FIGURE 2 MICE MODEL MARKET: BREAKDOWN OF PRIMARIES 42
2.2 MARKET ESTIMATION METHODOLOGY 42
FIGURE 3 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION) 43
FIGURE 4 MICE MODEL MARKET SIZE (USD MILLION) 44
FIGURE 5 MICE MODEL MARKET: FINAL CAGR PROJECTION (2023−2028) 44
FIGURE 6 MICE MODEL MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 45
2.3 MARKET DATA ESTIMATION AND TRIANGULATION 46
2.3.1 DATA TRIANGULATION 46
FIGURE 7 DATA TRIANGULATION METHODOLOGY 46
2.4 INDUSTRY INSIGHTS 47
2.5 STUDY ASSUMPTIONS 47
2.6 RECESSION IMPACT: MICE MODEL MARKET 48
TABLE 1 GLOBAL INFLATION RATE PROJECTION, 2023–2028 (% GROWTH) 48
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 48
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION) 48
3 EXECUTIVE SUMMARY 50
FIGURE 8 MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2023 VS. 2028 (USD MILLION) 50
FIGURE 9 MICE MODEL MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION) 51
FIGURE 10 MICE MODEL MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 51
FIGURE 11 MICE MODEL MARKET: GEOGRAPHICAL SNAPSHOT 52
4 PREMIUM INSIGHTS 53
4.1 MICE MODEL MARKET OVERVIEW 53
FIGURE 12 INCREASING DEMAND FOR MOUSE-BASED CLINICAL TRIALS TO DRIVE MARKET 53
4.2 NORTH AMERICA: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE (2022) 54
FIGURE 13 MICE MODELS SEGMENT IN THE US ACCOUNTED FOR LARGEST MARKET SHARE 54
4.3 MICE MODEL MARKET SHARE, BY END USER, 2023 VS. 2028 54
FIGURE 14 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 54
4.4 MICE MODEL MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 55
FIGURE 15 CHINA TO REGISTER HIGHEST GROWTH RATE IN ASIA PACIFIC MARKET DURING FORECAST PERIOD 55
5 MARKET OVERVIEW 56
5.1 INTRODUCTION 56
5.2 MARKET DYNAMICS 56
FIGURE 16 MICE MODEL MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 56
TABLE 4 MICE MODEL MARKET: IMPACT ANALYSIS 57
5.2.1 DRIVERS 57
5.2.1.1 Rising investments in mouse model-based research 57
5.2.1.2 Increasing demand for mouse-based clinical trials (MCTs) 58
5.2.1.3 Growing preference for personalized medicine 58
5.2.2 RESTRAINTS 59
5.2.2.1 Introduction of 3D-printed mouse models 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Utilization of CRISPR in biomedical research 59
5.2.4 CHALLENGES 60
5.2.4.1 Development of alternative animal testing methods 60
5.3 TECHNOLOGY ANALYSIS 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 61
FIGURE 17 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 61
5.5 SUPPLY AND VALUE CHAIN ANALYSIS 62
5.5.1 MICE MODEL MARKET: SUPPLY CHAIN ANALYSIS 62
FIGURE 18 MICE MODEL MARKET: SUPPLY CHAIN MAP 62
5.5.2 MICE MODEL MARKET: VALUE CHAIN MAP 63
FIGURE 19 MICE MODEL MARKET: VALUE CHAIN MODEL 63
5.6 ECOSYSTEM ANALYSIS 64
FIGURE 20 MICE MODEL MARKET: ECOSYSTEM MAP 64
5.7 PORTER’S FIVE FORCES ANALYSIS 64
TABLE 5 MICE MODEL MARKET: PORTER’S FIVE FORCES ANALYSIS 64
5.7.1 THREAT OF NEW ENTRANTS 64
5.7.2 THREAT OF SUBSTITUTES 65
5.7.3 BARGAINING POWER OF BUYERS 65
5.7.4 BARGAINING POWER OF SUPPLIERS 65
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 65
5.8 REGULATORY ANALYSIS 66
5.8.1 INTRODUCTION 66
5.8.2 NORTH AMERICA 66
5.8.3 EUROPE 67
5.8.4 CHINA 68
5.8.5 JAPAN 68
5.8.6 INDIA 69
5.8.7 AUSTRALIA 70
5.8.8 BRAZIL 70
5.9 PATENT ANALYSIS 70
FIGURE 21 MICE MODEL MARKET: PATENT FILING TRENDS (2010-2022) 70
5.10 PRICING ANALYSIS 71
TABLE 6 AVERAGE SELLING PRICE OF PRODUCTS BY MANUFACTURERS 71
5.10.1 MICE MODEL MARKET: AVERAGE SELLING PRICE TREND ANALYSIS 71
5.11 KEY CONFERENCES 72
5.11.1 MICE MODEL MARKET: KEY CONFERENCES (2023) 72
TABLE 7 MICE MODEL MARKET: KEY CONFERENCES (2023) 72
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 72
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 72
FIGURE 22 MICE MODEL MARKET: INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS 72
5.12.2 MICE MODEL MARKET: KEY BUYING CRITERIA 73
FIGURE 23 KEY BUYING CRITERIA FOR END USERS 73
6 MICE MODEL MARKET, BY MODEL TYPE AND SERVICE 74
6.1 INTRODUCTION 75
TABLE 8 MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021–2028 (USD MILLION) 75
6.2 MODEL TYPE 75
6.2.1 INTRODUCTION 75
TABLE 9 MICE MODEL MARKET, BY MODEL TYPE, 2021–2028 (USD MILLION) 75
6.2.2 INBRED MICE 76
6.2.2.1 Growing applications of inbred mice in mAb production and pharmacology to drive market 76
TABLE 10 INBRED MICE MODEL MARKET, BY REGION, 2021–2028 (USD MILLION) 76
TABLE 11 NORTH AMERICA: INBRED MICE MODEL MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 76
TABLE 12 EUROPE: INBRED MICE MODEL MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 77
TABLE 13 ASIA PACIFIC: INBRED MICE MODEL MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 77
6.2.3 OUTBRED MICE 77
6.2.3.1 Genetic diversity offered by outbred mice to drive market 77
TABLE 14 OUTBRED MICE MODEL MARKET, BY REGION, 2021–2028 (USD MILLION) 78
TABLE 15 NORTH AMERICA: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 78
TABLE 16 EUROPE: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 78
TABLE 17 ASIA PACIFIC: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 79
6.2.4 GENETICALLY ENGINEERED MICE 79
6.2.4.1 Increasing focus on personalized medicine for cancer and CVD to drive segment growth 79
TABLE 18 GENETICALLY ENGINEERED MICE MODEL MARKET, BY REGION, 2021–2028 (USD MILLION) 80
TABLE 19 NORTH AMERICA: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 80
TABLE 20 EUROPE: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 80
TABLE 21 ASIA PACIFIC: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 81
6.2.5 HYBRID/CONGENIC MICE 81
6.2.5.1 Increasing demand for congenic mice in biomedical research to drive market 81
TABLE 22 HYBRID/CONGENIC MICE MODEL MARKET, BY REGION, 2021–2028 (USD MILLION) 81
TABLE 23 NORTH AMERICA: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 82
TABLE 24 EUROPE: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 82
TABLE 25 ASIA PACIFIC: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 82
6.3 SERVICES 83
6.3.1 INTRODUCTION 83
TABLE 26 MICE MODEL MARKET, BY SERVICES, 2021–2028 (USD MILLION) 83
6.3.2 BREEDING SERVICES 83
6.3.2.1 Growing number of mice model studies to fuel market 83
TABLE 27 MICE MODEL MARKET FOR BREEDING SERVICES, BY REGION, 2021–2028 (USD MILLION) 84
TABLE 28 NORTH AMERICA: MICE MODEL MARKET FOR BREEDING SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 29 EUROPE: MICE MODEL MARKET FOR BREEDING SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 30 ASIA PACIFIC: MICE MODEL MARKET FOR BREEDING SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 85
 
6.3.3 CRYOPRESERVATION SERVICES 85
6.3.3.1 Rising need for preservation of novel mice models to drive market 85
TABLE 31 MICE MODEL MARKET FOR CRYOPRESERVATION SERVICES, BY REGION, 2021–2028 (USD MILLION) 86
TABLE 32 NORTH AMERICA: MICE MODEL MARKET FOR CRYOPRESERVATION SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 86
TABLE 33 EUROPE: MICE MODEL MARKET FOR CRYOPRESERVATION SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 86
TABLE 34 ASIA PACIFIC: MICE MODEL MARKET FOR CRYOPRESERVATION SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 87
6.3.4 REDERIVATION SERVICES 87
6.3.4.1 Stringent quality assurance standards to drive market 87
TABLE 35 MICE MODEL MARKET FOR REDERIVATION SERVICES, BY REGION, 2021–2028 (USD MILLION) 87
TABLE 36 NORTH AMERICA: MICE MODEL MARKET FOR REDERIVATION SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 88
TABLE 37 EUROPE: MICE MODEL MARKET FOR REDERIVATION SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 88
TABLE 38 ASIA PACIFIC: MICE MODEL MARKET FOR REDERIVATION SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 88
6.3.5 QUARANTINE SERVICES 89
6.3.5.1 Rising demand for germ-free mice in histopathology and serology applications to drive market 89
TABLE 39 MICE MODEL MARKET FOR QUARANTINE SERVICES, BY REGION, 2021–2028 (USD MILLION) 89
TABLE 40 NORTH AMERICA: MICE MODEL MARKET FOR QUARANTINE SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 89
TABLE 41 EUROPE: MICE MODEL MARKET FOR QUARANTINE SERVICE, BY COUNTRY, 2021–2028 (USD MILLION) 90
TABLE 42 ASIA PACIFIC: MICE MODEL MARKET FOR QUARANTINE SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 90
6.3.6 OTHER SERVICES 90
TABLE 43 MICE MODEL MARKET FOR OTHER SERVICES, BY REGION, 2021–2028 (USD MILLION) 91
TABLE 44 NORTH AMERICA: MICE MODEL MARKET FOR OTHER SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 91
TABLE 45 EUROPE: MICE MODEL MARKET FOR OTHER SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 92
TABLE 46 ASIA PACIFIC: MICE MODEL MARKET FOR OTHER SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 92
7 MICE MODEL MARKET, BY APPLICATION 93
7.1 INTRODUCTION 94
TABLE 47 MICE MODEL MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 94
7.2 DRUG DISCOVERY & DEVELOPMENT 94
7.2.1 RISING NUMBER OF CLINICAL TRIALS TO DRIVE DEMAND FOR MICE MODELS 94
TABLE 48 MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2021–2028 (USD MILLION) 95
TABLE 49 NORTH AMERICA: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 50 EUROPE: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 51 ASIA PACIFIC: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 96
7.3 BASIC RESEARCH 96
7.3.1 INCREASING FUNDS FOR CANCER RESEARCH ON MICE MODELS TO SUPPORT MARKET GROWTH 96
TABLE 52 MICE MODEL MARKET FOR BASIC RESEARCH, BY REGION, 2021–2028 (USD MILLION) 97
TABLE 53 NORTH AMERICA: MICE MODEL MARKET MODEL MARKET FOR BASIC RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 97
TABLE 54 EUROPE: MICE MODEL MARKET FOR BASIC RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 97
TABLE 55 ASIA PACIFIC: MICE MODEL MARKET FOR BASIC RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 98
7.4 PDX MODELS/ XENOGRAFTS 98
7.4.1 GROWING PREFERENCE FOR PERSONALIZED MEDICINE IN IMMUNODEFICIENT MICE MODELS TO DRIVE MARKET 98
TABLE 56 MICE MODEL MARKET FOR PDX MODELS/XENOGRAFTS, BY REGION, 2021–2028 (USD MILLION) 99
TABLE 57 NORTH AMERICA: MICE MODEL MARKET FOR PDX MODELS/XENOGRAFTS, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 58 EUROPE: MICE MODEL MARKET FOR PDX MODELS/XENOGRAFTS, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 59 ASIA PACIFIC: MICE MODEL MARKET FOR PDX MODELS/XENOGRAFTS, BY COUNTRY, 2021–2028 (USD MILLION) 100
8 MICE MODEL MARKET, BY TECHNOLOGY 101
8.1 INTRODUCTION 102
TABLE 60 MICE MODEL MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 102
8.2 CRISPR/CAS9 102
8.2.1 HIGH EFFICIENCY AND COST-EFFECTIVE BENEFITS TO DRIVE DEMAND FOR CRISPR-CUSTOMIZED MODELS 102
TABLE 61 MICE MODEL MARKET, BY REGION, 2021–2028 (USD MILLION) 103
TABLE 62 NORTH AMERICA: MICE MODEL MARKET FOR CRISPR/CAS9, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 63 EUROPE: MICE MODEL MARKET FOR CRISPR/CAS9 TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 64 ASIA PACIFIC: MICE MODEL MARKET FOR CRISPR/CAS9, BY COUNTRY, 2021–2028 (USD MILLION) 104
8.3 MICROINJECTION 104
8.3.1 WIDELY UTILIZED TECHNIQUE FOR DEVELOPMENT OF TRANSGENIC MICE MODELS TO DRIVE MARKET 104
TABLE 65 NORTH AMERICA: MICE MODEL MARKET FOR MICROINJECTION, BY COUNTRY, 2021–2028 (USD MILLION) 104
TABLE 66 EUROPE: MICE MODEL MARKET FOR MICROINJECTION, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 67 ASIA PACIFIC: MICE MODEL MARKET FOR MICROINJECTION, BY COUNTRY, 2021–2028 (USD MILLION) 105
8.4 EMBRYONIC STEM CELL INJECTION 105
8.4.1 GROWING DEMAND FOR TARGETED MICE MODELS TO DRIVE MARKET 105
TABLE 68 NORTH AMERICA: MICE MODEL MARKET FOR EMBRYONIC STEM CELL INJECTION, BY COUNTRY, 2021–2028 (USD MILLION) 106
TABLE 69 EUROPE: MICE MODEL MARKET FOR EMBRYONIC STEM CELL INJECTION, BY COUNTRY, 2021–2028 (USD MILLION) 106
TABLE 70 ASIA PACIFIC: MICE MODEL MARKET FOR EMBRYONIC STEM CELL INJECTION, BY COUNTRY, 2021–2028 (USD MILLION) 107
8.5 NUCLEAR TRANSFER 107
8.5.1 POTENTIAL TO PRODUCE IDENTICAL MICE TO DRIVE MARKET 107
TABLE 71 NORTH AMERICA: MICE MODEL MARKET FOR NUCLEAR TRANSFER, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 72 EUROPE: MICE MODEL MARKET FOR NUCLEAR TRANSFER, BY COUNTRY, 2021–2028 (USD MILLION) 108
TABLE 73 ASIA PACIFIC: MICE MODEL MARKET FOR NUCLEAR TRANSFER, BY COUNTRY, 2021–2028 (USD MILLION) 108
8.6 OTHER TECHNOLOGIES 109
TABLE 74 NORTH AMERICA: MICE MODEL MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 75 EUROPE: MICE MODEL MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 76 ASIA PACIFIC: MICE MODEL MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 110
9 MICE MODEL MARKET, BY END USER 111
9.1 INTRODUCTION 112
TABLE 77 MICE MODEL MARKET, BY END USER, 2021–2028 (USD MILLION) 112
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 112
9.2.1 EXTENSIVE USE OF MICE MODELS IN CANCER THERAPEUTICS TO DRIVE MARKET 112
TABLE 78 MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 113
TABLE 79 NORTH AMERICA: MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 113
TABLE 80 EUROPE: MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 81 ASIA PACIFIC: MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 114
9.3 CONTRACT RESEARCH ORGANIZATIONS AND CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS 115
9.3.1 RISING OUTSOURCING OF DRUG DISCOVERY SERVICES TO DRIVE MARKET 115
TABLE 82 MICE MODEL MARKET FOR CROS AND CDMOS, BY REGION, 2021–2028 (USD MILLION) 115
TABLE 83 NORTH AMERICA: MICE MODEL MARKET FOR CROS AND CDMOS, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 84 EUROPE: MICE MODEL MARKET FOR CROS AND CDMOS, BY COUNTRY, 2021–2028 (USD MILLION) 116
TABLE 85 ASIA PACIFIC: MICE MODEL MARKET FOR CROS AND CDMOS, BY COUNTRY, 2021–2028 (USD MILLION) 116
9.4 ACADEMIC & RESEARCH INSTITUTES 117
9.4.1 INCREASE IN GOVERNMENT LIFE SCIENCES R&D EXPENDITURE TO DRIVE MARKET 117
TABLE 86 MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 117
TABLE 87 NORTH AMERICA: MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 88 EUROPE: MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 89 ASIA PACIFIC: MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 118
10 MICE MODEL MARKET, BY REGION 119
10.1 INTRODUCTION 120
FIGURE 24 MICE MODEL MARKET, BY REGION, 2023 VS. 2028 (USD MILLION) 120
TABLE 90 MICE MODEL MARKET, BY REGION, 2021–2028 (USD MILLION) 120
10.2 NORTH AMERICA 121
FIGURE 25 NORTH AMERICA: MICE MODEL MARKET SNAPSHOT 121
TABLE 91 NORTH AMERICA: MICE MODEL MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 92 NORTH AMERICA: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021–2028 (USD MILLION) 122
TABLE 93 NORTH AMERICA: MICE MODEL MARKET, BY MODEL TYPE, 2021–2028 (USD MILLION) 122
TABLE 94 NORTH AMERICA: MICE MODEL MARKET, BY SERVICE, 2021–2028 (USD MILLION) 123
TABLE 95 NORTH AMERICA: MICE MODEL MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 123
TABLE 96 NORTH AMERICA: MICE MODEL MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 123
TABLE 97 NORTH AMERICA: MICE MODEL MARKET, BY END USER, 2021–2028 (USD MILLION) 124
10.2.1 US 124
10.2.1.1 Rising production of monoclonal antibodies to fuel market for mice models 124
TABLE 98 US: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021–2028 (USD MILLION) 125
TABLE 99 US: MICE MODEL MARKET, BY MODEL TYPE, 2021–2028 (USD MILLION) 125
TABLE 100 US: MICE MODEL MARKET, BY SERVICE, 2021–2028 (USD MILLION) 125
TABLE 101 US: MICE MODEL MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 126
TABLE 102 US: MICE MODEL MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 126
TABLE 103 US: MICE MODEL MARKET, BY END USER, 2021–2028 (USD MILLION) 126
10.2.2 CANADA 127
10.2.2.1 Rising activities in stem cell research to drive adoption of mice models 127
TABLE 104 CANADA: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021–2028 (USD MILLION) 127
TABLE 105 CANADA: MICE MODEL MARKET, BY MODEL TYPE, 2021–2028 (USD MILLION) 127
TABLE 106 CANADA: MICE MODEL MARKET, BY SERVICE, 2021–2028 (USD MILLION) 128
TABLE 107 CANADA: MICE MODEL MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 128
TABLE 108 CANADA: MICE MODEL MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 128
TABLE 109 CANADA: MICE MODEL MARKET, BY END USER, 2021–2028 (USD MILLION) 129
10.2.3 NORTH AMERICA: RECESSION IMPACT 129
10.3 EUROPE 130
TABLE 110 EUROPE: MICE MODEL MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 111 EUROPE: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021–2028 (USD MILLION) 130
TABLE 112 EUROPE: MICE MODEL MARKET, BY MODEL TYPE, 2021–2028 (USD MILLION) 131
TABLE 113 EUROPE: MICE MODEL MARKET, BY SERVICE, 2021–2028 (USD MILLION) 131
TABLE 114 EUROPE: MICE MODEL MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 131
TABLE 115 EUROPE: MICE MODEL MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 132
TABLE 116 EUROPE: MICE MODEL MARKET, BY END USER, 2021–2028 (USD MILLION) 132
10.3.1 GERMANY 132
10.3.1.1 Rising research activities in biotechnology industry to drive market 132
TABLE 117 GERMANY: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021–2028 (USD MILLION) 133
TABLE 118 GERMANY: MICE MODEL MARKET, BY MODEL TYPE, 2021–2028 (USD MILLION) 134
TABLE 119 GERMANY: MICE MODEL MARKET, BY SERVICE, 2021–2028 (USD MILLION) 134
TABLE 120 GERMANY: MICE MODEL MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 134
TABLE 121 GERMANY: MICE MODEL MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 135
TABLE 122 GERMANY: MICE MODEL MARKET, BY END USER, 2021–2028 (USD MILLION) 135
10.3.2 FRANCE 135
10.3.2.1 Rising research in proteomics & genomics to drive adoption of genetically engineered mice models 135
TABLE 123 FRANCE: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021–2028 (USD MILLION) 136
TABLE 124 FRANCE: MICE MODEL MARKET, BY MODEL TYPE, 2021–2028 (USD MILLION) 136
TABLE 125 FRANCE: MICE MODEL MARKET, BY SERVICE, 2021–2028 (USD MILLION) 136
TABLE 126 FRANCE: MICE MODEL MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 137
TABLE 127 FRANCE: MICE MODEL MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 137
TABLE 128 FRANCE: MICE MODEL MARKET, BY END USER, 2021–2028 (USD MILLION) 137
10.3.3 UK 138
10.3.3.1 Increasing focus on cancer research to drive market 138
TABLE 129 UK: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021–2028 (USD MILLION) 138
TABLE 130 UK: MICE MODEL MARKET, BY MODEL TYPE, 2021–2028 (USD MILLION) 138
TABLE 131 UK: MICE MODEL MARKET, BY SERVICE, 2021–2028 (USD MILLION) 139
TABLE 132 UK: MICE MODEL MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 139
TABLE 133 UK: MICE MODEL MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 139
TABLE 134 UK: MICE MODEL MARKET, BY END USER, 2021–2028 (USD MILLION) 140
10.3.4 ITALY 140
10.3.4.1 Rising demand for preclinical research in pharmaceutical & biotechnology industry to support market growth 140
TABLE 135 ITALY: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021–2028 (USD MILLION) 140
TABLE 136 ITALY: MICE MODEL MARKET, BY MODEL TYPE, 2021–2028 (USD MILLION) 141
TABLE 137 ITALY: MICE MODEL MARKET, BY SERVICE, 2021–2028 (USD MILLION) 141
TABLE 138 ITALY: MICE MODEL MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 141
TABLE 139 ITALY: MICE MODEL MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 142
TABLE 140 ITALY: MICE MODEL MARKET, BY END USER, 2021–2028 (USD MILLION) 142
10.3.5 SPAIN 142
10.3.5.1 High number of pharmaceutical laboratories to fuel market for mice models 142
TABLE 141 SPAIN: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021–2028 (USD MILLION) 143
TABLE 142 SPAIN: MICE MODEL MARKET, BY MODEL TYPE, 2021–2028 (USD MILLION) 143
TABLE 143 SPAIN: MICE MODEL MARKET, BY SERVICE, 2021–2028 (USD MILLION) 143
TABLE 144 SPAIN: MICE MODEL MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 144
TABLE 145 SPAIN: MICE MODEL MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 144
TABLE 146 SPAIN: MICE MODEL MARKET, BY END USER, 2021–2028 (USD MILLION) 144
10.3.6 REST OF EUROPE 145
TABLE 147 REST OF EUROPE: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021–2028 (USD MILLION) 145
TABLE 148 REST OF EUROPE: MICE MODEL MARKET, BY MODEL TYPE, 2021–2028 (USD MILLION) 145
TABLE 149 REST OF EUROPE: MICE MODEL MARKET, BY SERVICE, 2021–2028 (USD MILLION) 146
TABLE 150 REST OF EUROPE: MICE MODEL MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 146
TABLE 151 REST OF EUROPE: MICE MODEL MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 146
TABLE 152 REST OF EUROPE: MICE MODEL MARKET, BY END USER, 2021–2028 (USD MILLION) 147
10.3.7 EUROPE: RECESSION IMPACT 147
10.4 ASIA PACIFIC 148
FIGURE 26 ASIA PACIFIC: MICE MODEL MARKET SNAPSHOT 148
TABLE 153 ASIA PACIFIC: MICE MODEL MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 149
TABLE 154 ASIA PACIFIC: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021–2028 (USD MILLION) 149
TABLE 155 ASIA PACIFIC: MICE MODEL MARKET, BY MODEL TYPE, 2021–2028 (USD MILLION) 149
TABLE 156 ASIA PACIFIC: MICE MODEL MARKET, BY SERVICE, 2021–2028 (USD MILLION) 150
TABLE 157 ASIA PACIFIC: MICE MODEL MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 150
TABLE 158 ASIA PACIFIC: MICE MODEL MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 150
TABLE 159 ASIA PACIFIC: MICE MODEL MARKET, BY END USER, 2021–2028 (USD MILLION) 151
10.4.1 JAPAN 151
10.4.1.1 Increasing focus on advancements in mice model technologies to drive market 151
TABLE 160 JAPAN: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021–2028 (USD MILLION) 151
TABLE 161 JAPAN: MICE MODEL MARKET, BY MODEL TYPE, 2021–2028 (USD MILLION) 152
TABLE 162 JAPAN: MICE MODEL MARKET, BY SERVICE, 2021–2028 (USD MILLION) 152
TABLE 163 JAPAN: MICE MODEL MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 152
TABLE 164 JAPAN: MICE MODEL MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 153
TABLE 165 JAPAN: MICE MODEL MARKET, BY END USER, 2021–2028 (USD MILLION) 153
10.4.2 CHINA 153
10.4.2.1 International alliances for R&D activities to drive adoption of mice models 153
TABLE 166 CHINA: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021–2028 (USD MILLION) 154
TABLE 167 CHINA: MICE MODEL MARKET, BY MODEL TYPE, 2021–2028 (USD MILLION) 154
TABLE 168 CHINA: MICE MODEL MARKET, BY SERVICE, 2021–2028 (USD MILLION) 154
TABLE 169 CHINA: MICE MODEL MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 155
TABLE 170 CHINA: MICE MODEL MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 155
TABLE 171 CHINA: MICE MODEL MARKET, BY END USER, 2021–2028 (USD MILLION) 155
10.4.3 INDIA 156
10.4.3.1 Rising initiatives in drug discovery development to fuel uptake of inbred mice 156
TABLE 172 INDIA: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021–2028 (USD MILLION) 156
TABLE 173 INDIA: MICE MODEL MARKET, BY MODEL TYPE, 2021–2028 (USD MILLION) 156
TABLE 174 INDIA: MICE MODEL MARKET, BY SERVICE, 2021–2028 (USD MILLION) 157
TABLE 175 INDIA: MICE MODEL MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 157
TABLE 176 INDIA: MICE MODEL MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 157
TABLE 177 INDIA: MICE MODEL MARKET, BY END USER, 2021–2028 (USD MILLION) 158
10.4.4 SOUTH KOREA 158
10.4.4.1 Rising R&D investments in drug development to fuel uptake for genetically engineered mice models 158
TABLE 178 SOUTH KOREA: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021–2028 (USD MILLION) 158
TABLE 179 SOUTH KOREA: MICE MODEL MARKET, BY MODEL TYPE, 2021–2028 (USD MILLION) 159
TABLE 180 SOUTH KOREA: MICE MODEL MARKET, BY SERVICE, 2021–2028 (USD MILLION) 159
TABLE 181 SOUTH KOREA: MICE MODEL MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 159
TABLE 182 SOUTH KOREA: MICE MODEL MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 160
TABLE 183 SOUTH KOREA: MICE MODEL MARKET, BY END USER, 2021–2028 (USD MILLION) 160
10.4.5 AUSTRALIA 160
10.4.5.1 High number of research institutes to drive market for mouse-based clinical trials 160
TABLE 184 AUSTRALIA: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021–2028 (USD MILLION) 161
TABLE 185 AUSTRALIA: MICE MODEL MARKET, BY MODEL TYPE, 2021–2028 (USD MILLION) 161
TABLE 186 AUSTRALIA: MICE MODEL MARKET, BY SERVICE, 2021–2028 (USD MILLION) 161
TABLE 187 AUSTRALIA: MICE MODEL MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 162
TABLE 188 AUSTRALIA: MICE MODEL MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 162
TABLE 189 AUSTRALIA: MICE MODEL MARKET, BY END USER, 2021–2028 (USD MILLION) 162
10.4.6 REST OF ASIA PACIFIC 163
TABLE 190 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021–2028 (USD MILLION) 163
TABLE 191 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY MODEL TYPE, 2021–2028 (USD MILLION) 163
TABLE 192 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY SERVICE, 2021–2028 (USD MILLION) 164
TABLE 193 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 164
TABLE 194 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 164
TABLE 195 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY END USER, 2021–2028 (USD MILLION) 165
10.4.7 ASIA PACIFIC: RECESSION IMPACT 165
 
10.5 LATIN AMERICA 166
10.5.1 GROWING PHARMACEUTICAL INDUSTRY AND DRUG DEVELOPMENT ACTIVITIES TO SUPPORT MARKET GROWTH 166
TABLE 196 LATIN AMERICA: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021–2028 (USD MILLION) 166
TABLE 197 LATIN AMERICA: MICE MODEL MARKET, BY MODEL TYPE, 2021–2028 (USD MILLION) 166
TABLE 198 LATIN AMERICA: MICE MODEL MARKET, BY SERVICE, 2021–2028 (USD MILLION) 167
TABLE 199 LATIN AMERICA: MICE MODEL MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 167
TABLE 200 LATIN AMERICA: MICE MODEL MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 167
TABLE 201 LATIN AMERICA: MICE MODEL MARKET, BY END USER, 2021–2028 (USD MILLION) 168
10.5.2 LATIN AMERICA: RECESSION IMPACT 168
10.6 MIDDLE EAST & AFRICA 169
10.6.1 RISING EXPANSION OF PHARMACEUTICAL FACTORIES TO SUPPORT MARKET GROWTH 169
TABLE 202 MIDDLE EAST & AFRICA: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021–2028 (USD MILLION) 169
TABLE 203 MIDDLE EAST & AFRICA: MICE MODEL MARKET, BY MODEL TYPE, 2021–2028 (USD MILLION) 170
TABLE 204 MIDDLE EAST & AFRICA: MICE MODEL MARKET, BY SERVICE, 2021–2028 (USD MILLION) 170
TABLE 205 MIDDLE EAST & AFRICA: MICE MODEL MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 170
TABLE 206 MIDDLE EAST & AFRICA: MICE MODEL MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 171
TABLE 207 MIDDLE EAST & AFRICA: MICE MODEL MARKET, BY END USER, 2021–2028 (USD MILLION) 171
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 171
11 COMPETITIVE LANDSCAPE 172
11.1 INTRODUCTION 172
11.2 STRATEGIES ADOPTED BY KEY PLAYERS 172
FIGURE 27 MICE MODEL MARKET: STRATEGIES ADOPTED BY KEY PLAYERS 173
11.3 REVENUE SHARE ANALYSIS (TOP 4 PLAYERS) 174
FIGURE 28 REVENUE ANALYSIS FOR TOP 4 COMPANIES (2020−2022) 174
FIGURE 29 MICE MODEL MARKET: MARKET SHARE ANALYSIS OF TOP 4 PLAYERS (2022) 175
11.4 COMPANY EVALUATION QUADRANT FOR GLOBAL PLAYERS 176
11.4.1 STARS 176
11.4.2 EMERGING LEADERS 176
11.4.3 PERVASIVE PLAYERS 177
11.4.4 PARTICIPANTS 177
FIGURE 30 MICE MODEL MARKET: COMPANY EVALUATION MATRIX FOR GLOBAL PLAYERS (2022) 177
11.5 COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES 178
11.5.1 PROGRESSIVE COMPANIES 178
11.5.2 STARTING BLOCKS 178
11.5.3 RESPONSIVE COMPANIES 178
11.5.4 DYNAMIC COMPANIES 178
FIGURE 31 MICE MODEL MARKET: STARTUPS/SMES EVALUATION QUADRANT (2022) 179
11.5.5 COMPETITIVE BENCHMARKING 180
11.5.5.1 Mice Model Market: List of Startups/SMEs 180
TABLE 208 MICE MODEL MARKET: DETAILED LIST OF STARTUPS/SMES 180
11.5.5.2 Mice Model Market: Competitive Benchmarking Of Key Players (Startups/SMEs) 181
TABLE 209 MICE MODEL MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (STARTUPS/SMES) 181
11.6 COMPETITIVE SCENARIO AND TRENDS 182
11.6.1 PRODUCT LAUNCHES 182
TABLE 210 MICE MODEL MARKET: PRODUCT LAUNCHES 182
11.6.2 DEALS 182
TABLE 211 MICE MODEL MARKET: DEALS 182
11.6.3 OTHER DEVELOPMENTS 184
TABLE 212 MICE MODEL MARKET: OTHER DEVELOPMENTS 184
12 COMPANY PROFILES 185
12.1 KEY PLAYERS 185
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
12.1.1 CHARLES RIVER LABORATORIES 185
TABLE 213 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW 185
FIGURE 32 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2022) 186
12.1.2 THE JACKSON LABORATORY 191
TABLE 214 THE JACKSON LABORATORY: COMPANY OVERVIEW 191
FIGURE 33 THE JACKSON LABORATORY: COMPANY SNAPSHOT 191
12.1.3 INOTIV 195
TABLE 215 INOTIV: COMPANY OVERVIEW 195
FIGURE 34 INOTIV: COMPANY SNAPSHOT 196
12.1.4 GENOWAY 201
TABLE 216 GENOWAY: COMPANY OVERVIEW 201
FIGURE 35 GENOWAY: COMPANY SNAPSHOT (2022) 201
12.1.5 TACONIC BIOSCIENCES, INC. 204
TABLE 217 TACONIC BIOSCIENCES, INC.: COMPANY OVERVIEW 204
12.1.6 JANVIER LABS 207
TABLE 218 JANVIER LABS: COMPANY OVERVIEW 207
12.1.7 HARBOUR BIOMED 209
TABLE 219 HARBOUR BIOMED: BUSINESS OVERVIEW 209
FIGURE 36 HARBOUR BIOMED: COMPANY SNAPSHOT (2021) 209
12.1.8 TRANS GENIC INC. 211
TABLE 220 TRANS GENIC INC.: COMPANY OVERVIEW 211
FIGURE 37 TRANS GENIC INC.: COMPANY SNAPSHOT (2021) 211
12.1.9 INGENIOUS TARGETING LABORATORY 213
TABLE 221 INGENIOUS TARGETING LABORATORY: COMPANY OVERVIEW 213
12.1.10 POLYGENE 215
TABLE 222 POLYGENE AG: COMPANY OVERVIEW 215
12.1.11 ARAGEN LIFE SCIENCES LTD. 216
TABLE 223 ARAGEN LIFE SCIENCES LTD.: COMPANY OVERVIEW 216
12.1.12 CYAGEN BIOSCIENCES 218
TABLE 224 CYAGEN BIOSCIENCES: COMPANY OVERVIEW 218
12.1.13 CROWN BIOSCIENCE 220
TABLE 225 CROWN BIOSCIENCE: BUSINESS OVERVIEW 220
12.1.14 TRANSCURE BIOSERVICES 222
TABLE 226 TRANSCURE BIOSERVICES: COMPANY OVERVIEW 222
12.1.15 OZGENE PTY LTD. 223
TABLE 227 OZGENE PTY LTD.: BUSINESS OVERVIEW 223
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
12.2 OTHER PLAYERS 224
12.2.1 THE ANDERSONS, INC. 224
12.2.2 ALLENTOWN, LLC 224
12.2.3 INNOVIVE 225
12.2.4 LAB PRODUCTS, LLC. 225
12.2.5 CRESCENDO BIOLOGICS 226
12.2.6 IMMUNOGENES 226
12.2.7 LEXICON PHARMACEUTICALS, INC. 227
12.2.8 HORIZON DISCOVERY LTD. 227
12.2.9 MARSHALL BIORESOURCES 228
12.2.10 APPLIED STEMCELL 228
13 APPENDIX 229
13.1 DISCUSSION GUIDE 229
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 232
13.3 CUSTOMIZATION OPTIONS 234
13.4 RELATED REPORTS 234
13.5 AUTHOR DETAILS 235